FCGR2A and neoplasm: Antigen presenting cells use FcgR-mediated endocytosis of immune complexes and phagocytosis of antibody-coated tumour cells as efficient means of tumour antigen processing and presentation, which can result in tumour-directed T-cell immunity [12].